1-3 of 3
Michael Roughton
Close
Sort by
Journal Articles

Dabrafenib, Alone or in Combination with Trametinib, in Pediatric Patients with BRAF V600 Mutation-Positive Langerhans Cell Histiocytosis

James A. Whitlock, Birgit Geoerger, Michael Roughton, Jeea Choi, Lisa Osterloh, Mark Russo, Darren Hargrave
Journal: Blood
Blood (2021) 138 (Supplement 1): 3618.
https://doi.org/10.1182/blood-2021-147377
Published: 2021
Journal Articles

Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution

Clinical Trials & Observations
Ronjon Chakraverty, Guillermo Orti, Michael Roughton, Jun Shen, Adele Fielding, Panagiotis Kottaridis, Donald Milligan, Matthew Collin, Charles Crawley, Peter Johnson, Andrew Clark, Anne Parker, Adrian Bloor, Ruth Pettengell, John Snowden, Andrew Pettitt, Richard Clark, Geoff Hale, Karl Peggs, Kirsty Thomson, Emma Morris, Stephen Mackinnon
Journal: Blood
Blood (2010) 116 (16): 3080–3088.
https://doi.org/10.1182/blood-2010-05-286856
Published: 2010
Journal Articles

Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphoma

Clinical Trials & Observations
Jonathan R. Lambert, Jamshed B. Bomanji, Karl S. Peggs, Kirsty J. Thomson, Ronjon K. Chakraverty, Adele K. Fielding, Panagiotis D. Kottaridis, Michael Roughton, Emma C. Morris, Anthony H. Goldstone, David C. Linch, Peter J. Ell, Stephen Mackinnon
Journal: Blood
Blood (2010) 115 (14): 2763–2768.
https://doi.org/10.1182/blood-2009-11-255182
Published: 2010